merck glp-1 moves into obesity with deal for Hansoh's pill Merck Partners with Hansoh Pharma
Description
T., Heslinga, M
In a study of diabetic patients, exenatide was found to transiently suppress the expression of inflammatory markers TNF and IL-1
JARDIANCE reduces the risk of cardiovascular death in adults with type 2 diabetes who have known cardiovascular disease
doi: 10.1056/NEJMoa2416394
[6] Ablymico contains the same active substance as Saxenda, but it is chemically synthesized, whereas the active substance in the reference products is of biological origin
